Eledon submits tegoprubart islet transplantation IND; first patients enrolled
Eledon Pharmaceuticals submitted an IND to the FDA for an Eledon-sponsored registrational tegoprubart islet cell transplantation study for type 1 diabetes. It also enrolled first patients in a new investigator-initiated tegoprubart study in renal dysfunction patients.